PPARGC1A and cardiomyopathy: Although we did not determine NRF-1 levels in the heart, several studies reported NRF-1 was activated by PGC-1α to increase mitochondrial biogenesis and increased oxidative capacity in the pathologic heart such as heart failure and cardiomyopathy [47–50].